KFSHRC And SFDA Join Forces To Strengthen Pharmaceutical Safety Research In Saudi Arabia

The King Faisal Specialist Hospital & Research Centre (KFSHRC) has formed a collaboration with the Saudi Food and Drug Authority (SFDA). This partnership is designed to enhance the national safety database by providing essential data assets. The information will aid in research focused on pharmaceutical product safety, supporting evidence-based decisions that improve public health and safety regulations.

The agreement was formalised during the Global Health Exhibition in Riyadh. It was signed by Dr. Majid bin Ibrahim Alfayyadh, Chief Executive of KFSHRC, and Dr. Hisham bin Saad Aljadhey, Chief Executive of SFDA. Executives from both organisations were present at the signing, alongside other attendees of the event.

Under this agreement, KFSHRC and SFDA commit to maintaining high standards of cybersecurity and privacy. They will employ advanced encryption technologies approved by regulators to protect the confidentiality and integrity of information assets during their transmission and exchange.

The data involved includes a range of demographic and medical information. This encompasses age, gender, marital status, chronic diseases, surgeries, medical examinations, and diagnostic procedures. Such comprehensive data is crucial for enhancing research on pharmaceutical product safety.

This collaboration is part of broader efforts to advance research on pharmaceutical product safety. It aims to improve healthcare quality by minimising potential risks and developing modern safety standards that address evolving health challenges.

Additionally, the partnership seeks to maximise the benefits of medical data in advancing research and scientific studies. These efforts are intended to improve the health and safety of individuals as well as the community at large.

KFSHRC's Global Recognition

KFSHRC has achieved significant recognition for its contributions to healthcare. It has been ranked first in the Middle East and Africa and 20th globally among the world’s top 250 Academic Medical Centers for two consecutive years. Furthermore, it has been acknowledged as the most valuable healthcare brand in Saudi Arabia and the Middle East according to Brand Finance's 2024 rankings.

In addition to these accolades, KFSHRC was also listed among the world's best 250 hospitals by Newsweek magazine for 2025. It was included in their World’s Best Smart Hospitals list as well.

This partnership between KFSHRC and SFDA represents a significant step forward in enhancing pharmaceutical safety research while ensuring data security and privacy are upheld at all times.

With inputs from SPA